skip to Main Content
CBD’s National Rollout Requires Execution, Not Just Excitement

With CVS, Walgreens and Rite-Aid all moving in lock step with CBD products, general retailers are now required to develop their own CBD related strategies. Such was the focus at last week’s CBD and the Future of Cannabis conference, where convenience store operators learned more about the opportunities with CBD. And for a group that has seen their already slim margins shrink due to lower cigarette sales, CBD offers a new high-growth item to stock.

The ubiquity of drug stores and c-stores will almost assuredly accelerate the growth of CBD. In research conducted for The CBD Consumer Experience: Part One, accessibility was identified as one of the key factors holding back consumer usage. Even among current CBD users, 43% reported that they would use CBD more frequently if they had easier access to products, while 30% of non-users reported the same. In the more general cannabis market, inconvenient dispensary locations is one of the key drivers for illegal cannabis usage, cited by a quarter of recreational users in 2018’s Adult Use Consumer report. With many consumers in adult-use and medical-states living in cannabis deserts, sparse dispensary coverage is obviously a limiting factor.

While CBD products are available online, for new customers who are not familiar with CBD, seeing these products in a well-known and trusted store lends credibility and assurances. Even for those customers who regularly use CBD today, opening the market by another potential 21,000 locations (combined CVS, Walgreens and Rite-Aid footprint) will undoubtedly lead to greater consumer acceptance and usage.

CBD’s Gain May Cause Dispensary Pain

Current cannabis dispensaries should take note here. It’s true that CBD has been sold in many health food stores over the years, but those stores do not have the same general consumer audience as drug and c-stores. The stores’ massive footprints and no requirement for either a medical card or ID scan makes it ideal for consumers looking for a convenient outlet, without the layers of security and checks required in cannabis dispensaries. For the CBD segments identified in The CBD Consumer Experience: Part One, notably Goop-y Gwyneths and Dosing Dads, the combination of convenient locations and purchase experience will be appealing.

Growth That Needs Management

The prospects of CBD’s mainstreaming into general retail are certainly positive but there are risks that these retailers need to navigate, including the sales and usage of CBD products among those under 18 years old. With a number of c-stores already under watch for sales of e-cigarettes to minors, CBD and cannabis operators need to push their retail partners to strictly adhere to the letter and the spirit of local laws regulating CBD product sales.

But the larger concern that these new retailers must address is actually a fairly simple one—where to stock these products. Do they belong on shelves, mixed in with their adjacent product categories, like snacks, candy, beauty products, etc.? Do they belong behind the counter, the “back bar”? Or do they belong at the checkout but behind lock and key?

Due to shrinkage concerns and risk averseness to sales to minors, it’s likely that CBD products will be placed behind the counter. In time, it may be that CBD products make their way onto the shelves, mixed in with general wellness products. But as an entirely new product category, operators should be pushing for checkout location with select high-volume categories that make sense at such a location—food items, beverages and concentrates. Each retailer will determine the best level of security for these products, but placement in a high-traffic zone is key.

Employee Engagement is Necessary

Lastly, product placement may not matter if the people meant to provide customer service know little about the products. And for the CBD industry, that will be a challenge that will require long-term investment and clarity. As consumers learn and read more about CBD, they’ll likely ask about derivations, intended effects, usage occasions and comparisons to other CBD brands. Vague or noncommittal answers are not a good experience for any party—the sales clerk, the customer or the CBD brand. In this regard, the challenge for CBD is a universal one for brands in drug stores and c-stores, but it does not diminish this challenge’s importance.

CBD’s introduction into mainstream retail is not without peril, but the growth opportunity for manufacturers and retailers is significant. Getting this right is not only important for the opportunity at hand, but also for the long-term push to end cannabis prohibition nationally.

Eric Giandelone

Eric Giandelone

Eric Giandelone is the co-founder of High Yield Insights. High Yield Insights is a consumer-insights firm dedicated to the cannabis market, fostering constructive, fact-based discussions that lead to well-grounded strategic decisions. With deep roots in multiple consumer-facing industries, High Yield Insights brings decades of expertise to this dynamic, quickly evolving market.

Eric can be reached directly at [email protected].

This Post Has 0 Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

Recent Stories

Kentucky’s Medical Cannabis Program Undergoes Dramatic Transformation: Navigating HB 829 and the Emergency Licensing Regulations

By Hannah King and Arin Aragona Plans for Kentucky’s medical cannabis program took a significant turn last week with the passage of House Bill 829 and the implementation of emergency…

Cannabis in Court: When Federal Courts Will Hear Commercial Disputes Related to the Cannabis Business

By Steven Ascher and Anna M.Windemuth The unique status of the cannabis business —  legal in a majority of states, but still illegal under federal law — creates a thorny…

Patchwork Regulation of CBD Products Continues Despite Rise in Demand

By Courtney A. Hunter and Jessalyn H. Zeigler Demand for cannabidiol (CBD) products continues to climb, and the market has risen to the occasion. There is now a robust array…

How Private Equity Trumped Social Equity in State Cannabis Deal

Confidential documents obtained by THE CITY reveal how Chicago Atlantic Group became one of the biggest beneficiaries of the state’s legalization program. Last June, Gov. Kathy Hochul announced that a…

More Categories

Back To Top
×Close search
Search